| |
 |
|
Class Information
Number: 424/185.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same
Description: Subject matter wherein an amino acid sequence specifying an antigen, an epitope, or another immunospecific immunoeffector is disclosed in whole or in part, wherein the disclosed amino acid sequence may be part of a conjugate, a complex, or a fusion protein or fusion polypeptide.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6652858 |
Use of OX-2 to suppress an immune response |
Nov. 25, 2003 |
| 6652859 |
PTANS: testis specific proteins expressed in prostate cancer |
Nov. 25, 2003 |
| 6652860 |
Peptide, apoEp 1.B, compositions and uses thereof |
Nov. 25, 2003 |
| 6652861 |
Anti-HIV and anti-tumor peptides and truncated polypeptides of MAP30 |
Nov. 25, 2003 |
| 6652862 |
Biologically active bactericidal/permeability-increasing protein fragments |
Nov. 25, 2003 |
| 6652863 |
Method of reducing the immunogenicity of compounds |
Nov. 25, 2003 |
| 6653084 |
Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor |
Nov. 25, 2003 |
| 6653444 |
Polypeptides comprising a B7 extracellular domain |
Nov. 25, 2003 |
| 6649166 |
Peptides and proteins for desensitizing subjects allergic to bee venom and compositions containing same |
Nov. 18, 2003 |
| 6649171 |
Moraxella catarrahalis polynucleotides and polypeptides |
Nov. 18, 2003 |
| 6649374 |
Recombinant Chlamydia trachomatis PGP3 antigen |
Nov. 18, 2003 |
| 6649737 |
Human galactosyltranferases |
Nov. 18, 2003 |
| 6645498 |
Soluble variants of type I membrane proteins, and methods of using them |
Nov. 11, 2003 |
| 6645499 |
Human ena/VASP-like protein splice variant |
Nov. 11, 2003 |
| 6645500 |
Method for down-regulating osteoprotegerin ligand activity |
Nov. 11, 2003 |
| 6645505 |
Reporter gene based method for the screening of anti-tuberculosis drugs by using essential and regulatory genes of mycobacteria as drug target |
Nov. 11, 2003 |
| 6645728 |
Inhibitor of the inflammatory response induced by TNF.alpha. and IL-1 |
Nov. 11, 2003 |
| 6641813 |
Methods and reagents for diagnosis of autoantibodies |
Nov. 4, 2003 |
| 6642354 |
Molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
Nov. 4, 2003 |
| 6638512 |
Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens |
Oct. 28, 2003 |
| 6635249 |
Methods for treating congestive heart failure |
Oct. 21, 2003 |
| 6635255 |
CASB414:antigen overexpressed in several tumors |
Oct. 21, 2003 |
| 6635257 |
Particles of HCV envelope proteins: use for vaccination |
Oct. 21, 2003 |
| 6635258 |
Herpes simplex virus VP22 vaccines and methods of use |
Oct. 21, 2003 |
| 6635259 |
Escherichia coli secreted protein B |
Oct. 21, 2003 |
| 6635472 |
Retrovirus and viral vectors |
Oct. 21, 2003 |
| 6632434 |
Leptospiral major outer membrane protein, LipL 32 |
Oct. 14, 2003 |
| 6632441 |
Mutants of streptococcal toxin a and methods of use |
Oct. 14, 2003 |
| 6630148 |
Compositions comprising hedgehog proteins |
Oct. 7, 2003 |
| 6627200 |
Utilization of CD 137 in order to promote the proliferation of peripheral monocytes |
Sep. 30, 2003 |
| 6627204 |
Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
Sep. 30, 2003 |
| 6627728 |
Compounds from moraxella catarrhalis |
Sep. 30, 2003 |
| 6627735 |
Islet cell antigen 1851 |
Sep. 30, 2003 |
| 6623735 |
Vaccine containing a thiol protease |
Sep. 23, 2003 |
| 6623740 |
Structurally modified peptides that are resistant to peptidase degradation |
Sep. 23, 2003 |
| 6613333 |
Immunodominant human T-cell epitopes of hepatitis C virus |
Sep. 2, 2003 |
| 6613337 |
Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Sep. 2, 2003 |
| 6613536 |
Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
Sep. 2, 2003 |
| 6613883 |
Screening assays for compounds that cause apoptosis and related compounds |
Sep. 2, 2003 |
| 6610297 |
Peptide immunogens for vaccination against and treatment of allergy |
Aug. 26, 2003 |
| 6610661 |
Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
Aug. 26, 2003 |
| 6607726 |
Human tumor necrosis factor receptor TR10 |
Aug. 19, 2003 |
| 6607729 |
Surface antigen |
Aug. 19, 2003 |
| 6607730 |
Chlamydia antigens and corresponding DNA fragments and uses thereof |
Aug. 19, 2003 |
| 6607731 |
Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
Aug. 19, 2003 |
| 6608187 |
C1 bacteriophage lytic system |
Aug. 19, 2003 |
| 6605280 |
Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18 |
Aug. 12, 2003 |
| 6605287 |
Vaccines for Chlamydia psittaci infections |
Aug. 12, 2003 |
| 6605588 |
Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
Aug. 12, 2003 |
| 6605699 |
Galectin-11 polypeptides |
Aug. 12, 2003 |
|
|
|
